Book value compounding
Net worth compounded at 19.3% a year over 7 years (₹10,670 → ₹36,767).
Importance 57 / 95 · financial health
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Net worth compounded at 19.3% a year over 7 years (₹10,670 → ₹36,767).
Importance 57 / 95 · financial health
Revenue compounded at 17.0% a year over 7 years (₹15,164 → ₹45,509).
Importance 56 / 95 · growth
ROE of 11.2% is well above the investment company median of 6.2%.
Importance 55 / 95 · profitability
Classified by the exchange under Financial Services › Financial Services › Finance › Investment Company.
Peer set used on this page: 2 investment company.
Revenue grew 17.0% a year over 7 years, from ₹15,164 cr in FY2019 to ₹45,509 cr in FY2026. Net profit grew 25.0% a year over the same period.
Revenue compounded at 17.0% a year over 7 years (₹15,164 → ₹45,509).
Rule REVENUE_CAGR_STRONG
Over 7 years profit compounded at 25.0% a year while revenue compounded at 17.0% a year — though FY2023 saw a one-off step-change of 191% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Net profit grew 13.3% year on year (FY2025 → FY2026).
In Q2 FY27 (Jul–Sep 2026), revenue was ₹14,003 cr (up 32.2% on the same quarter last year) and net profit ₹1,353 cr (up 53.4%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹1,353 cr, up 53.4% from ₹882 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 revenue was ₹14,003 cr, up 32.2% from ₹10,595 cr in Q2 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q2 FY27 EBIT was ₹5,277 cr, up 34.0% from ₹3,939 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 9,381 | +6.6% | 724 | −4.7% | 7.7% |
| Q4 FY25 | 12,214 | +11.6% | 886 | −31.2% | 7.3% |
| Q1 FY26 | 9,503 | +7.6% | 851 | +9.2% | 9.0% |
| Q2 FY26 | 10,595 | +2.6% | 882 | −13.5% | 8.3% |
| Q3 FY26 | 11,952 | +27.4% | 966 | +33.3% | 8.1% |
| Q4 FY26 | 13,459 | +10.2% | 1,165 | +31.5% | 8.7% |
| Q1 FY27 | 12,180 | +28.2% | 1,224 | +43.9% | 10.0% |
| Q2 FY27 | 14,003 | +32.2% | 1,353 | +53.4% | 9.7% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
No verified corporate actions on record for this company.
Net margin was 8.5% in FY2026 (5.3% in FY2019); ROE 11.2%; ROA 1.3%.
ROE of 11.2% is well above the investment company median of 6.2%.
Rule ROE_ABOVE_PEER_MEDIAN
Net worth was ₹36,767 cr in FY2026.
Net worth compounded at 19.3% a year over 7 years (₹10,670 → ₹36,767).
Rule NET_WORTH_COMPOUNDING
Its peer group is too small for a meaningful ranking.
Ranked against 2 investment company (FY2026, consolidated).
Not enough peers in this set report the underlying metrics yet for a ranking.
Trades at 23.54× earnings — 56% below the investment company median of 53.54×.
Rule PE_BELOW_PEERS
On the trailing twelve months. Last full year: P/E 28.7× · P/S 2.4× · ROE 11.2%. TTM and full-year profit differ by more than 15% — a one-off in a recent quarter is moving the trailing figure; weigh it against the full year.
The share price is up 29.0% over 1 year, up 146% over 3 years (35.1% a year) and up 312% over 5 years (32.7% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is at its 52-week high.
Long-term price performance is shown above.
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15,164 | 16,792 | 19,248 | 22,230 | 27,416 | 34,506 | 40,590 | 45,509 |
| Total income | 15,172 | 16,810 | 19,274 | 22,241 | 30,201 | 34,561 | 40,724 | 45,617 |
| EBITDA | 5,322 | 5,748 | 5,307 | 5,547 | 10,229 | 12,090 | 14,366 | 16,803 |
| Profit before tax | 1,155 | 1,029 | 1,277 | 1,946 | 5,363 | 4,278 | 4,426 | 4,820 |
| Net profit | 811 | 866 | 1,106 | 1,660 | 4,824 | 3,439 | 3,410 | 3,864 |
| EPS (₹) | 4.0 | 4.1 | 4.7 | 7.1 | 19.8 | 13.1 | 12.8 | 14.4 |
| Net worth | 10,670 | 13,895 | 15,227 | 17,091 | 21,820 | 28,638 | 32,347 | 36,767 |
| Operating cash flow | — | — | −308 | −5,070 | −24,053 | −24,101 | −27,935 | −36,544 |
| Free cash flow | — | — | −458 | −5,247 | −24,293 | −24,499 | −28,382 | −36,905 |
| Ratio | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||
| Revenue growth YoY | — | 10.7 | 14.6 | 15.5 | 23.3 | 25.9 | 17.6 | 12.1 |
| Profit growth YoY | — | 6.8 | 27.7 | 50.1 | 190.6 | -28.7 | -0.8 | 13.3 |
| Profitability | ||||||||
| EBITDA margin % | 35.1 | 34.2 | 27.6 | 25.0 | 37.3 | 35.0 | 35.4 | 36.9 |
| Net margin % | 5.3 | 5.2 | 5.7 | 7.5 | 16.0 | 10.0 | 8.4 | 8.5 |
| Return on equity % | 7.6 | 7.1 | 7.6 | 10.3 | 24.8 | 13.6 | 11.2 | 11.2 |
| Return on capital % | — | — | — | — | — | — | — | — |
| Leverage & cash | ||||||||
| Debt to equity | — | — | — | — | — | — | — | — |
| Cash flow ÷ profit | — | — | -0.28 | -3.05 | -4.99 | -7.01 | -8.19 | -9.46 |
| Current ratio | — | — | — | — | — | — | — | — |